Science Applications Competitors

Stocks . USA . 
Stock . Science Applications International
SAIC Stock  USD 92.66  -1.27  -1.35%   
For benchmarking purposes, Science Applications International is compared with Paysafe, Avnet, NIQ Global, Verra Mobility, and Ingram Micro and related companies. Revenue per employee for Science Applications versus peers measures operational efficiency at a basic level.

Science Applications and Concentrix Correlation Summary

Excellent diversification
Across the chosen horizon, Science Applications and Concentrix show a correlation of -0.17 and fall into the Excellent diversification bucket. This chart measures the degree of risk overlap between Science Applications and Concentrix.
Diversification Candidates
  0.58MI NFT LimitedPairCorr
  0.57DTT0 DATATEC LTD 2PairCorr
  0.54DM Datametrex AIPairCorr
  0.46AMI amalphi agPairCorr
Specify up to 10 symbols:
The mean reversion principle applied to Science Applications' suggests that neither prolonged outperformance nor underperformance is permanent. Identifying the root cause of Science Applications' price dislocation is essential before acting on a mean reversion signal. The mean reversion tendency in Science Applications' price is a well-documented phenomenon in academic research. In many cases, Science Applications' price extremes present statistical patterns that have recurred historically.
Sentiment
Range
LowSentimentHigh
90.3293.1295.92
Details
Intrinsic
Valuation
LowIntrinsicHigh
83.76245.22248.02
Details
Naive
Forecast
LowNextHigh
90.4793.2696.06
Details
Analyst
Consensus
LowTargetHigh
99.90109.78121.85
Details
Competitive analysis for Science Applications compares its financial performance and valuation metrics against sector peers. Cross-sectional comparison separates idiosyncratic performance from sector-level dynamics. Science Applications' metrics are most informative when compared against the strongest and weakest performers in its sector. Cross-company comparison helps validate or challenge assumptions embedded in Science Applications' current valuation.

Science Applications Competition Correlation Matrix

Studying peer correlation around Science Applications International provides a cleaner read on how much independent price behavior still exists across the competitive set. When interpreted alongside fundamentals, correlation analysis separates broad industry exposure from company-specific behavior before additional capital is allocated across the peer group.

High positive correlations

PAY
+ 0.9
PSFE
SLAB
+ 0.9
AVT
INGM
+ 0.87
PSFE
VICR
+ 0.87
AVT
SLAB
+ 0.85
INGM
VICR
+ 0.84
PSFE
  

High negative correlations

CNXC
- 0.71
SLAB
CNXC
- 0.6
INGM
CNXC
- 0.57
VICR
CNXC
- 0.54
AVT
INGM
- 0.51
VRRM
CNXC
- 0.48
PSFE

Risk-Adjusted Indicators

Strong recent returns in Science Stock do not always mean Science Applications Company is outperforming peers on business quality. Without risk-adjusted context, short-term returns may appear stronger than the volatility required to achieve them would suggest. These indicators are quantitative in nature and measure volatility and risk-adjusted expected returns across different positions.

Peer Comparison: Net Income

Net income is what remains after all costs — operating expenses, interest, taxes, and preferred dividends — are deducted from Science Applications's total revenue. The relationship between net income growth and revenue growth at Science Applications reveals whether margin expansion is driving earnings or whether top-line growth is being consumed by rising costs and financing charges.
Compare Science Applications and related stocks such as Paysafe, Avnet Inc, and NIQ Global Intelligence Net Income Over Time
Select Fundamental
Price To Sales RatioDividend Yield
Ptb RatioDays Sales Outstanding
Book Value Per ShareFree Cash Flow Yield
Invested CapitalOperating Cash Flow Per Share
Average PayablesStock Based Compensation To Revenue
Capex To DepreciationPb Ratio
Ev To SalesFree Cash Flow Per Share
RoicInventory Turnover
Net Income Per ShareDays Of Inventory On Hand
Payables TurnoverSales General And Administrative To Revenue
Average InventoryResearch And Ddevelopement To Revenue
Capex To RevenueCash Per Share
PocfratioInterest Coverage
Payout RatioCapex To Operating Cash Flow
Pfcf RatioDays Payables Outstanding
Net Current Asset ValueIncome Quality
RoeTangible Asset Value
Ev To Operating Cash FlowPe Ratio
Return On Tangible AssetsEv To Free Cash Flow
Earnings YieldIntangibles To Total Assets
Net Debt To EBITDACurrent Ratio
Tangible Book Value Per ShareReceivables Turnover
Graham NumberShareholders Equity Per Share
Debt To EquityCapex Per Share
Graham Net NetAverage Receivables
Revenue Per ShareInterest Debt Per Share
Debt To AssetsShort Term Coverage Ratios
Price Earnings RatioOperating Cycle
Price Book Value RatioPrice Earnings To Growth Ratio
Days Of Payables OutstandingDividend Payout Ratio
Price To Operating Cash Flows RatioPrice To Free Cash Flows Ratio
Pretax Profit MarginEbt Per Ebit
Operating Profit MarginEffective Tax Rate
Company Equity MultiplierLong Term Debt To Capitalization
Total Debt To CapitalizationReturn On Capital Employed
Debt Equity RatioEbit Per Revenue
Quick RatioDividend Paid And Capex Coverage Ratio
Net Income Per EBTCash Ratio
Cash Conversion CycleOperating Cash Flow Sales Ratio
Days Of Inventory OutstandingDays Of Sales Outstanding
Free Cash Flow Operating Cash Flow RatioCash Flow Coverage Ratios
Price To Book RatioFixed Asset Turnover
Capital Expenditure Coverage RatioPrice Cash Flow Ratio
Enterprise Value MultipleDebt Ratio
Cash Flow To Debt RatioPrice Sales Ratio
Return On AssetsAsset Turnover
Net Profit MarginGross Profit Margin
Price Fair ValueReturn On Equity
20102011201220132014201520162017201820192020202120222023202420252026
PSFE-39.7 M-39.7 M-39.7 M-39.7 M-39.7 M-39.7 M-39.7 M-39.7 M-39.7 M-110.2 M-126.7 M-111 M-1.9 B-20.3 M22.2 M-182.5 M-191.6 M
AVT23.9 M567 M450.1 M545.6 M571.9 M506.5 M525.3 M-156.4 M176.3 M-31.1 M193.1 M692.4 M770.8 M498.7 M240.2 M276.2 M209.5 M
VRRM11.4 M11.4 M11.4 M11.4 M11.4 M11.4 M29 M1.4 M-58.4 M17.1 M-4.6 M41.4 M92.5 M57 M31.4 M136.6 M143.5 M
INGM310.6 M310.6 M310.6 M310.6 M266.7 M215.1 M100.4 M199 M352.2 M503.6 M640.5 M475.2 M2.4 B352.7 M264.2 M327.9 M541.8 M
PAY-63.8 M282.4 M65 M-296.1 M-38.1 M79.1 M-9.3 M-173.9 M13.7 M13.7 M13.7 M9.3 M-513 K22.3 M44.2 M66.9 M70.3 M
VICR2.5 M8.8 M-4.1 M-23.6 M-13.9 M4.9 M-6.2 M167 K31.7 M14.1 M17.9 M56.6 M25.4 M53.6 M6.1 M118.6 M124.5 M
DLO15.6 M15.6 M15.6 M15.6 M15.6 M15.6 M15.6 M15.6 M15.6 M15.6 M28.2 M77.9 M108.7 M149 M120.4 M196.8 M109.5 M
SLAB11 M35.5 M63.5 M49.8 M38 M29.6 M61.5 M47.1 M83.6 M19.3 M12.5 M2.1 B91.4 M-34.5 M-191 M-64.9 M-61.7 M
CNXC72.2 M72.2 M72.2 M72.2 M72.2 M72.2 M72.2 M48.3 M117.2 M164.8 M405.6 M435 M313.8 M251.2 M-1.3 B-1.2 B-1.1 B

Science Applications Competitive Analysis

How does Science Applications measure up against Paysafe, Avnet, and NIQ Global? The financials tell a nuanced story. Science Applications operates at a 4.05 B scale with 7.26 B flowing through the income statement. The company converts revenue to profit at a 4.93% rate and delivers 23.27% on shareholder equity. Market capitalization diverges sharply here: 4.05 B versus 479.6 M, giving Science Applications a clear size advantage. Science Applications keeps more of each revenue dollar with a 4.93% margin versus 0.86% at Avnet. The market prices Science Applications more richly at 30.77x earnings, while NIQ Global trades at 18.78x.
    
 Better Than Average     
    
 Worse Than Peers    View Performance Chart
SAIC PSFE AVT NIQ VRRM INGM PAY
 1.35 
92.66
Science
 6.03 
8.72
Paysafe
 0.94 
82.86
Avnet
 5.88 
10.09
NIQ Global
 0.00 
13.81
Verra Mobility
 0.74 
27.00
Ingram Micro
 0.11 
26.67
Paymentus
Market Volatility
(90 Days Market Risk)
Very Low
Very Low
Very Low
Stable
Very Low
Very Low
Low
Market Performance
(90 Days Performance)
Weak
Moderate
Balanced
Soft
Weak
Moderate
Mild
Odds of Financial Distress
(Probability Of Bankruptcy)
Low
High
Minimal
Low
Minimal
Minimal
Minimal
Current Valuation
(Equity Enterprise Value)
Below Model Estimate
Below Model Estimate
Below Model Estimate
Below Model Estimate
Below Model Estimate
Below Model Estimate
Above Model Estimate
Buy or Sell Analysis
(Average Analysts Consensus)
Buy
Hold
Hold
Not Available
Strong Buy
Strong Buy
Not Available
Trade Advice
(90 Days Macroaxis Advice)
Cautious Hold
Strong Buy
Strong Buy
Hold
Hold
Hold
Sell
Return On Asset TTM
0.0634
0.0169
0.0344
N/A
0.0918
0.032
0.0759
Total Asset TTM
5.35 B
4.8 B
12.12 B
N/A
1.65 B
21.24 B
667.88 M
Net Income TTM
358 M
-182.51 M
240.22 M
N/A
136.63 M
327.88 M
66.94 M
Total Debt TTM
2.71 B
2.66 B
2.88 B
N/A
38.23 M
908.95 M
11.41 M
Retained Earnings TTM
1.49 B
-2.42 B
3.43 B
N/A
-243.76 M
1.59 B
162.85 M
Current Liabilities TTM
688 M
N/A
4.94 B
N/A
N/A
N/A
538.8 M
Net Asset
5.35 B
4.8 B
12.12 B
N/A
1.65 B
21.24 B
667.88 M
Current Ratio TTM
1.07 X
1.06 X
2.04 X
N/A
2.11 X
N/A
2.68 X
Price To Book TTM
2.70 X
0.73 X
1.36 X
3.20 X
7.99 X
1.50 X
5.74 X
Current Valuation
6.55 B
2.88 B
9.7 B
6.52 B
3.22 B
9.19 B
3.02 B
Five Year Return
1.68 %
N/A
2.18 %
1.99 %
N/A
N/A
N/A
One Year Return
N/A
N/A
N/A
2.20 %
N/A
N/A
N/A
Cash And Equivalents TTM
99 M
220.19 M
80.88 M
N/A
92.77 M
N/A
320.91 M
Number Of Employees
23 K
2.9 K
14.87 K
21
1.89 K
22.2 K
1.34 K
Shares Outstanding
43.1 M
51.25 M
82.02 M
282 M
151.91 M
231.65 M
62.94 M
Three Year Return
N/A
N/A
N/A
-0.66 %
N/A
N/A
N/A
Debt To Equity TTM
1.59 %
2.96 %
0.64 %
N/A
5.15 %
N/A
0.04 %
Annual Yield
0.0158
N/A
0.0168
N/A
N/A
0.0119
N/A
Current Asset TTM
952 M
N/A
9 B
N/A
N/A
N/A
757.43 M
Trailing Beta
0.27
1.83
1.11
0.03
0.67
N/A
1.4
Return On Equity TTM
0.23
-0.24
0.0435
N/A
0.46
0.0886
0.13
Profit Margin TTM
0.0493
-0.11
0.0086
N/A
0.13
0.0066
0.0559
Number Of Shares Shorted
2.92 M
3.15 M
7.37 M
N/A
3.16 M
4.22 M
1.99 M
Price To Sales TTM
0.56 X
0.28 X
0.27 X
0.75 X
2.22 X
0.12 X
2.80 X
Book Value Per Share TTM
34.09 X
12.68 X
60.38 X
N/A
1.91 X
18.07 X
4.46 X
Target Price
109.78
8.89
81.5
19.23
21.71
31.35
34.29
Last Dividend Paid
1.48
N/A
1.38
0.35
N/A
0.32
N/A
Shares Owned By Institutions
93.92 %
57.40 %
98.89 %
N/A
98.99 %
99.99 %
96.60 %
EBITDA TTM
664 M
396.54 M
747.76 M
N/A
375.92 M
1.26 B
116.6 M
Price To Earnings TTM
30.77 X
N/A
5.78 X
18.78 X
32.98 X
N/A
249.23 X
Price To Earnings To Growth
3.67 X
N/A
2.65 X
N/A
0.55 X
N/A
10.96 X
Gross Profit TTM
879 M
960.19 M
2.61 B
N/A
557.35 M
3.61 B
296.34 M
Market Capitalization TTM
4.05 B
479.56 M
6.73 B
3.16 B
2.17 B
6.3 B
3.35 B
Earnings Per Share
7.70 X
-3.14 X
2.59 X
N/A
0.82 X
1.52 X
0.57 X
Short Ratio TTM
4.29 X
8.33 X
7.96 X
N/A
1.78 X
2.98 X
4.78 X
Operating Margin TTM
0.0909
0.0599
0.0312
N/A
0.23
0.0167
0.0728
Cash Per Share TTM
1.80 X
0.30 X
0.86 X
N/A
0.61 X
N/A
1.29 X
Working Capital TTM
197 M
336.33 M
5.89 B
N/A
230.44 M
4.56 B
342.48 M
Shares Owned By Insiders
0.74 %
28.87 %
1.11 %
N/A
1.01 %
0.96 %
3.40 %
Revenue TTM
7.26 B
1.7 B
22.2 B
N/A
979.08 M
52.56 B
1.2 B
Cash Flow From Operations TTM
609 M
236.16 M
724.5 M
N/A
255.8 M
916.13 M
162.13 M
Year To Date Return
N/A
N/A
N/A
2.33 %
N/A
N/A
N/A
Day Typical Price
92.68
8.88
82.92
10.29
13.93
27.19
26.74
Accumulation Distribution
13887.86
18621.46
11715.41
96046.66
115619.0
39676.93
48579.12
Daily Balance Of Power
-0.50
-0.89
0.562
-0.75
N/A
-0.33
0.0195
Period Momentum Indicator
-1.27
-0.56
0.77
-0.63
N/A
-0.20
0.03
Rate Of Daily Change
0.99
0.94
1.01
0.94
1.0
0.99
1.0
Day Median Price
92.69
8.97
82.95
10.39
13.99
27.29
26.77
Price Action Indicator
-0.66
-0.52
0.3
-0.62
-0.17
-0.38
-0.09
Relative Strength Index
48.42
57.75
66.86
44.32
34.32
52.23
52.22
Coefficient Of Variation
-16,555
735.71
545.1
-2,123
-597.45
915.32
2185.2
Mean Deviation
1.7
2.86
1.63
2.75
1.44
2.33
2.03
Jensen Alpha
-0.03
0.5591
0.4034
-0.17
-0.39
0.4052
0.1187
Total Risk Alpha
-0.02
0.5643
0.4056
-0.17
-0.39
0.411
0.1227
Sortino Ratio
N/A
0.1738
0.2438
N/A
N/A
0.0864
0.0332
Downside Variance
N/A
10.28
2.73
N/A
N/A
21.93
12.75
Standard Deviation
2.76
4.16
2.24
3.53
2.3
3.78
2.77
Kurtosis
16.9
6.95
3.53
0.3565
15.68
7.81
0.895
Potential Upside
3.59
6.89
4.15
6.18
2.56
4.34
4.01
Treynor Ratio
0.5279
0.2927
0.3087
-0.24
-0.62
0.3347
0.1192
Maximum Drawdown
17.41
27.49
13.02
18.36
16.23
30.64
13.84
Variance
7.6
17.28
5.01
12.47
5.3
14.26
7.65
Market Risk Adjusted Performance
0.5379
0.3027
0.3187
-0.23
-0.61
0.3447
0.1292
Risk Adjusted Performance
7.0E-4
0.1387
0.1826
-0.04
-0.16
0.1128
0.0506
Skewness
-2.92
1.6
1.24
0.1676
-2.72
-0.82
-0.66
Semi Deviation
N/A
2.91
1.41
N/A
N/A
3.96
3.26
Information Ratio
-0.01
0.134
0.1799
-0.05
-0.17
0.1072
0.0429
Value At Risk
-3.11
-3.99
-2.40
-5.79
-2.75
-4.80
-5.46
Expected Short fall
N/A
-3.31
-1.98
N/A
N/A
-2.25
-1.72
Downside Deviation
N/A
3.21
1.65
N/A
N/A
4.68
3.57
Semi Variance
N/A
8.49
1.99
N/A
N/A
15.66
10.66

Science Applications Competition Peer Performance Charts

How to Analyze Science Applications Against Peers

Science Applications' peer analysis compares Science Applications with related companies to put valuation, quality, and risk metrics in context. This establishes whether recent performance is company-specific or broadly sector-driven. A practical workflow includes:
  • Set a relevant peer group: Include direct competitors and close alternatives with comparable business exposure.
  • Benchmark core financials: Compare profitability, growth, capital structure, and cash flow quality.
  • Check valuation dispersion: Review whether Science Applications trades at a premium or discount versus peers and why.
  • Evaluate risk profile: Compare volatility, drawdowns, and correlation to avoid false diversification assumptions.
  • Document the thesis: Record where Science Applications leads or lags and what catalysts could close or widen the gap.
Use this as an educational baseline, then validate conclusions with current filings, market conditions, and portfolio objectives.

Peer Comparison Metrics & Methodology

Revenue at Science Applications has grown faster than the peer median over the last four quarters, widening its competitive lead. Relative analysis can highlight whether current pricing already reflects peer-group strengths or weaknesses. For peer comparison, Science Applications has a market cap of 4.05 billion, P/E of 30.77, profit margin of 4.93%.

Reported values for Science Applications International are derived from periodic company reporting and market reference feeds and standardized for analysis. Analyst projections are included when active coverage applies.

Editorial review and methodology oversight provided by: Michael Smolkin, Member of Macroaxis Board of Directors
Tools
Analysis
Directory
Company
2026 Macroaxis LLC Made with in San Francisco
Privacy Terms Widgets Feedback
Macroaxis is not a registered investment advisor or broker/dealer. All investments, including stocks, funds, ETFs, or cryptocurrencies, are speculative and involve substantial risk of loss. We encourage our investors to invest carefully. Much of our information is derived directly from data published by companies or submitted to governmental agencies which we believe are reliable, but are without our independent verification. Therefore, we cannot assure you that the information is accurate or complete. We do not in any way warrant or guarantee the success of any action you take in reliance on our statements or recommendations. Also, note that past performance is not necessarily indicative of future results. All investments carry risk, and all investment decisions of an individual remain the responsibility of that individual. There is no guarantee that systems, indicators, or signals will result in profits or that they will not result in losses. All investors are advised to fully understand all risks associated with any investing they choose to do. Hypothetical or simulated performance is not indicative of future results. We make no representations or warranties that any investor will, or is likely to, achieve profits similar to those shown because hypothetical or simulated performance is not necessarily indicative of future results. For more information please visit our terms and conditions page.